首页> 外文OA文献 >Development Of Peptide Inhibitors Targeting Clostridium Difficile Toxins A/b And Characterizing The Regulatory Role Of A Putative Negative Regulator Tcdc In Clostridium Difficile Toxin Gene Expression
【2h】

Development Of Peptide Inhibitors Targeting Clostridium Difficile Toxins A/b And Characterizing The Regulatory Role Of A Putative Negative Regulator Tcdc In Clostridium Difficile Toxin Gene Expression

机译:靶向艰难梭菌毒素a / b的肽抑制剂的开发和表征推定的负调节因子Tcdc在艰难梭菌毒素基因表达中的调节作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Clostridium difficile infections cause one of the most common and vital hospitalacquireddiseases often associated with broad-spectrum antibiotic usage. TcdA and TcdBare the key virulence factors involved in major patho-physiology. While standardantibiotics provide some respite, due to the high relapse rates and the emergence of moresevere disease presentations, antibiotics alone have often proven to be suboptimal.Therefore there is a desperate need to develop an effective non-antimicrobialtherapeutics. Part of this work focuses on identification and further characterization ofpeptide therapeutic that target the major virulence factor TcdA/TcdB. Towardsdevelopment of mechanistic-based anti-toxin agent, phage display was used to identifypeptides that bind to the catalytic domain of C. difficile Toxin A. Characterization of thebinding and inhibitory activity revealed that the lack of parent peptide ability to inhibitthe cells in vivo. Further derivatization of above parent peptides in to irreversible binderslead to protects cells in vivo. Mass spectroscopy approaches revealed the peptideinhibition was mainly due to cross-linking of modified peptide in to key catalytic residuesin active site. While there are still several steps required to further explore in terms of thestability of these compounds, agents like these could be potentially used prophylactically163to avoid extensive cellular damage during treatment with broad spectrum antibiotics or inpopulations prone to CDI.The other area, focused on this thesis, is identification of the functional role of anegative regulator (TcdC) involved in toxin gene expression. In this work, we used avariety of biochemical and genetic approaches and characterized TcdC is not repressorinstead acts as an Extra Cytoplasmic Class (ECF) anti-sigma factor and was able topropose a new mechanistic model regarding the regulatory role of TcdC. As well as herewe have successfully developed GFP-based reporter system which has a potential to bean adaptable tool for investigating fine details on toxin genes tuning. Being able to adoptin host environment is vital for survival and propagation of a pathogenic bacteria. Thus,exploring the regulatory nodes on PaLoc gene expression can be lead to exploit potentialtherapeutic opportunities hidden within such systems.
机译:艰难梭菌感染是最常见和最重要的医院后遗症之一,通常与广谱抗生素的使用有关。 TcdA和TcdB是涉及主要病理生理的关键毒力因子。尽管标准抗生素提供了一定的喘息机会,但由于复发率高和出现更严重的疾病表现,单单抗生素常常被证明是次优的,因此迫切需要开发一种有效的非抗菌药物。这项工作的一部分重点在于针对主要毒力因子TcdA / TcdB的肽治疗剂的鉴定和进一步表征。为了发展基于机械的抗毒素剂,噬菌体展示被用于鉴定与艰难梭菌毒素A催化域结合的肽。结合和抑制活性的表征表明,缺乏母体肽在体内抑制细胞的能力。将上述亲本肽进一步衍生为不可逆的结合剂可在体内保护细胞。质谱方法揭示了肽抑制主要是由于修饰的肽与活性位点的关键催化残基交联。尽管就这些化合物的稳定性而言还需要进一步探索几个步骤,但是类似的药物可能会被预防性地使用163,以避免在广谱抗生素治疗或容易发生CDI的人群中造成广泛的细胞损伤。另一个领域是本文的重点是鉴定涉及毒素基因表达的负调节剂(TcdC)的功能作用。在这项工作中,我们使用了多种生化和遗传方法,并表征了TcdC不是阻遏物,而不是作为细胞质外类(ECF)的抗σ因子,并且能够提出有关TcdC调控作用的新机制模型。除此以外,我们还成功开发了基于GFP的报告系统,该系统可能具有适用于豆类的工具,可用于研究毒素基因调节的详细信息。能够在宿主环境中采用对于病原细菌的生存和繁殖至关重要。因此,探索PaLoc基因表达的调控节点可导致利用隐藏在此类系统中的潜在治疗机会。

著录项

  • 作者

    Abdeen Sanofar Jainul;

  • 作者单位
  • 年度 2013
  • 总页数
  • 原文格式 PDF
  • 正文语种
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号